How about our MSC's getting laced with a vaccine/antiviral and inhaled directly into the lungs of positive patients. Nice little revenue earner. Japan open to stem cell innovation, just our board will need a few more stock loans before we can move on.
- Forums
- ASX - By Stock
- CYP
- On track for Phase 2 clinical trials
On track for Phase 2 clinical trials, page-2
Featured News
Add CYP (ASX) to my watchlist
(20min delay)
|
|||||
Last
22.5¢ |
Change
0.005(2.27%) |
Mkt cap ! $39.74M |
Open | High | Low | Value | Volume |
22.0¢ | 22.5¢ | 22.0¢ | $20.74K | 94.23K |
Buyers (Bids)
No. | Vol. | Price($) |
---|---|---|
1 | 35950 | 22.0¢ |
Sellers (Offers)
Price($) | Vol. | No. |
---|---|---|
22.5¢ | 2766 | 1 |
View Market Depth
No. | Vol. | Price($) |
---|---|---|
2 | 35962 | 0.220 |
2 | 51511 | 0.215 |
3 | 34250 | 0.210 |
2 | 51780 | 0.205 |
3 | 31250 | 0.200 |
Price($) | Vol. | No. |
---|---|---|
0.225 | 2778 | 1 |
0.230 | 10000 | 1 |
0.235 | 33000 | 1 |
0.240 | 34000 | 3 |
0.250 | 19000 | 1 |
Last trade - 13.28pm 08/11/2024 (20 minute delay) ? |
Featured News
CYP (ASX) Chart |
The Watchlist
EQN
EQUINOX RESOURCES LIMITED.
Zac Komur, MD & CEO
Zac Komur
MD & CEO
SPONSORED BY The Market Online